242 related articles for article (PubMed ID: 32271388)
1. Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States.
Ogawa E; Yeo YH; Dang N; Le MH; Jeong D; Tran S; Henry L; Cheung R; Nguyen MH
JAMA Netw Open; 2020 Apr; 3(4):e201844. PubMed ID: 32271388
[TBL] [Abstract][Full Text] [Related]
2. Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019.
Pham TTH; Toy M; Hutton D; Thompson W; Conners EE; Nelson NP; Salomon JA; So S
Med Care; 2023 Apr; 61(4):247-253. PubMed ID: 36893410
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.
Chayanupatkul M; Omino R; Mittal S; Kramer JR; Richardson P; Thrift AP; El-Serag HB; Kanwal F
J Hepatol; 2017 Feb; 66(2):355-362. PubMed ID: 27693539
[TBL] [Abstract][Full Text] [Related]
4. The hepatitis B care cascade using administrative claims data, 2016.
Harris AM; Osinubi A; Nelson NP; Thompson WW
Am J Manag Care; 2020 Aug; 26(8):331-338. PubMed ID: 32835460
[TBL] [Abstract][Full Text] [Related]
5. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B.
Nguyen MH; Burak Ozbay A; Liou I; Meyer N; Gordon SC; Dusheiko G; Lim JK
J Hepatol; 2019 Jan; 70(1):24-32. PubMed ID: 30287341
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
Wong RJ; Jain MK; Therapondos G; Niu B; Kshirsagar O; Thamer M
Am J Gastroenterol; 2021 Jul; 116(7):1465-1475. PubMed ID: 33661148
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma incidence in noncirrhotic patients with chronic hepatitis B and patients with cirrhosis of all etiologies.
Do AL; Wong CR; Nguyen LH; Nguyen VG; Trinh H; Nguyen MH
J Clin Gastroenterol; 2014 Aug; 48(7):644-9. PubMed ID: 24201999
[TBL] [Abstract][Full Text] [Related]
8. Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg-positive high viral load chronic hepatitis B.
Nam JY; Chang Y; Cho H; Kang SH; Cho YY; Cho EJ; Lee JH; Yu SJ; Yoon JH; Kim YJ
J Viral Hepat; 2018 May; 25(5):552-560. PubMed ID: 29194870
[TBL] [Abstract][Full Text] [Related]
9. Modeling Progress Toward Elimination of Hepatitis B in Australia.
McCulloch K; Romero N; MacLachlan J; Allard N; Cowie B
Hepatology; 2020 Apr; 71(4):1170-1181. PubMed ID: 31419332
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
11. Real-world epidemiology, treatment patterns and disease burden of patients diagnosed with chronic hepatitis B in Taiwan.
Chien HT; Su TH; Huang H; Chiang CL; Lin FJ
Liver Int; 2023 Nov; 43(11):2404-2414. PubMed ID: 37615056
[TBL] [Abstract][Full Text] [Related]
12. Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.
Hsu YC; Yip TC; Ho HJ; Wong VW; Huang YT; El-Serag HB; Lee TY; Wu MS; Lin JT; Wong GL; Wu CY
J Hepatol; 2018 Aug; 69(2):278-285. PubMed ID: 29551708
[TBL] [Abstract][Full Text] [Related]
13. Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study.
Choi J; Kim HJ; Lee J; Cho S; Ko MJ; Lim YS
JAMA Oncol; 2019 Jan; 5(1):30-36. PubMed ID: 30267080
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States.
Toy M; Hutton D; Harris AM; Nelson N; Salomon JA; So S
Clin Infect Dis; 2022 Jan; 74(2):210-217. PubMed ID: 33956937
[TBL] [Abstract][Full Text] [Related]
15. Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
Tran S; Jeong D; Henry L; Cheung RC; Nguyen MH
Am J Gastroenterol; 2021 Sep; 116(9):1885-1895. PubMed ID: 33927125
[TBL] [Abstract][Full Text] [Related]
16. Comparison of overall survival between antiviral-induced viral suppression and inactive phase chronic hepatitis B patients.
Cho YY; Lee JH; Chang Y; Nam JY; Cho H; Lee DH; Cho EJ; Lee DH; Yu SJ; Lee JM; Kim YJ; Yoon JH
J Viral Hepat; 2018 Oct; 25(10):1161-1171. PubMed ID: 29741286
[TBL] [Abstract][Full Text] [Related]
17. Analysis of primary care electronic health record data of people living with hepatitis B virus: infection and hepatocellular carcinoma risk associated with socio-economic deprivation.
Campbell C; Wang T; Gillespie I; Barnes E; Matthews PC
Public Health; 2024 Jan; 226():215-227. PubMed ID: 38091810
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Hepatic Steatosis on the Natural History of HBV Infection.
Suliman I; Abdelgelil N; Kassamali F; Hassanein TI
Clin Liver Dis; 2019 Aug; 23(3):433-450. PubMed ID: 31266618
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Underuse and Overuse of Screening Tests for Co-occurring Conditions Among Children With Obesity.
Sharifi M; Goodman AB; Chua KP
JAMA Netw Open; 2022 Jul; 5(7):e2222101. PubMed ID: 35834247
[TBL] [Abstract][Full Text] [Related]
20. Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy.
Wang HW; Lai HC; Hu TH; Su WP; Lu SN; Lin CH; Hung CH; Chuang PH; Wang JH; Lee MH; Chen CH; Peng CY
J Gastroenterol Hepatol; 2019 Feb; 34(2):442-449. PubMed ID: 29968933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
